Low serum thiol levels predict shorter times-to-death among HIV-infected injecting drug users

AIDS

Volumn 11, Issue 11, 1997, Pages 1389-1393

  Marmor, Michael ^a   Alcabes, Philip ^a   Titus, Stephen ^a   Frenkel, Krystyna ^a   Krasinski, Keith ^a,b   Penn, Arthur ^a   Pero, Ronald W ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

^c OXiGENE Inc   (United States)

Author keywords

HIV; Injecting drug users; Oxidative stress; Serum thiols; Survival analysis

Indexed keywords

METHADONE; THIOL;

ARTICLE; BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIFE EXPECTANCY; METHADONE TREATMENT; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; SUBSTANCE ABUSE, INTRAVENOUS; SULFHYDRYL COMPOUNDS; SURVIVAL ANALYSIS;

EID: 0030815075     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199711000-00014     Document Type: Article

References (12)

1. Baruchel S, Wainberg M: The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leuk Biol 1992, 52:111-114.
2. Schreck R, Rieber P, Bauerle P: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991, 10:2247-2258.
3. Fuchs J, Schofer H, Milbradt R, et al.: Studies of lipoate effects on blood redox state in human immunodeficiency virus-infected patients. Arzneimittel Forschung Drug Res 1992, 43:1359-1362.
4. Pace G, Leaf C: The role of oxidative stress in HIV disease. Free Radical Biol Med 1995, 19:523-528.
5. Eck H, Gemunder H, Hartman M, Petzoldt D, Daniel V, Droge W: Low concentrations of acid-soluble thiols (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler 1989, 370:101-108.
6. Eck H, Stahl-Hennig C, Hunsmann G, Droge W: Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet 1991, 338:346-547.
7. Leff J, Oppegard M, Curiel T, Brown K, Schooley R, Repine J: Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. Free Radical Biol Med 1992, 13:143-149.
8. d'Onofrio G, Mancini S, Tamburrini E, Mango G, Ortona L: Giant neutrophils with increased peroxidase activity. Another evidence for dysgranulopoiesis in AIDS. Am J Clin Pathol 1987, 87:584-591.
9. Frankel K: Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 1992, 53:127-166.
10. Rosen G, Pou S, Ramos C, Cohen M, Britigan B: Free radicals and phagocytic cells. FASEB J 1995, 9:200-209.
11. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assocn 1958, 53:457-481.
12. Walmsley S, Harrison M, Winn L, Cosani D, Clark J, Utrecht J, Wells P: Increased oxidative stress in HIV patients reflected in plasma and lymphocyte thiol depletion. XI International Conference on AIDS. Vancouver, July 1996 [abstract TuA 2002].